Pharmaceutical Formulations comprising 1-substituted imidazoles, 1-substituted imidazoles and 1-substituted imidazoles for use in the treatment or prophylaxis of thrombo-embolic disorders
申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0000951A1
公开(公告)日:1979-03-07
The invention relates to the use in medicine of 1-alkylimidazoles of formula
in which A is a straight or branched, saturated or unsaturated acyclic hydrocarbon radical of from 1 to 3 carbon atoms; n is 0 or 1; and R is a cycloalkyl or cycloalkenyl radical of from 4 to 9 carbon atoms and optionally substituted by one, two, three or more alkyl radicals each containing from 1 to 4 carbon atoms, or, when n is 1, A and R together form an alkyl radical of from 4 to 7 carbon atoms or an alkenyl or alkynyl radical of from 4 to 9 carbon atoms, the imidazole being the free base or a pharmaceutically acceptable salt thereof.
The 1-alkylimidazoles in which n is 0 and R ist cycloalkyl or cycloalkenyl are novel, as are those when A and R together form an alkenyl radical.
Methods of preparing the 1-alkylimidazoles are disclosed.
The 1-alkylimidazoles have pharmacological properties of use in medicine, in particular for the treatment or prophylaxis of thrombo-embolic disorders.
本发明涉及式 1-烷基咪唑的医药用途。
其中 A 是 1 至 3 个碳原子的直链或支链、饱和或不饱和的无环烃基;n 是 0 或 1;和 R 是 4 至 9 个碳原子的环烷基或环烯烃基,并可选择被一个、两个、三个或多个烷基取代,每个烷基含有 1 至 4 个碳原子,或者,当 n 为 1 时,A 和 R 共同形成 4 至 7 个碳原子的烷基或 4 至 9 个碳原子的烯基或炔基,咪唑为游离基或其药学上可接受的盐。
n为0、R为环烷基或环烷烯基时的1-烷基咪唑是新颖的,A和R共同形成烯基时的1-烷基咪唑也是新颖的。
本发明公开了制备 1-烷基咪唑的方法。
1-烷基咪唑具有药理特性,可用于医药,特别是用于治疗或预防血栓栓塞性疾病。